Sunshine Biopharma (SBFM) Stock Price, Quote & News

Company Profile

Sunshine Biopharma, Inc. operates as a pharmaceutical company that engages in the research and development of life-saving medicines in various therapeutic areas, including oncology and antivirals in the United States and Canada. The company is developing SBFM-PL4, a protease inhibitor for the treatment of SARS coronavirus infections; and K1.1 mRNA, a lipid nano-particle for liver cancer. It also offers Essential 9, an amino acids capsules; Calcium-Vitamin D supplement under the Essential Calcium...

Industry: Drug Manufacturers - Specialty & Generic

Sector: Healthcare

Phone: 954 330 0684

Website: sunshinebiopharma.com

Address:

333 Las Olas Way, CU4 Suite 433, Fort Lauderdale, United States

Masterrunner Sep. 18 at 6:27 PM

$SBFM That's great news for Sandoz. If you want to be a shareholder in a real multi-billion dollar bio-similar global leader; here is the ticker $SDZNY. It doesn't dilute, toxic warrant & RS every 6 months like Dr Sleezyballs & his fake bio-pharma. NFA

2 · Reply

contra7 Sep. 18 at 6:00 PM

$SBFM https://www.sandoz.com/sandoz-receives-regulatory-approval-generic-semaglutide-canada-paving-way-expand-patient-access-key/

1 · Reply

Kalini67 Sep. 18 at 4:02 PM

$SBFM

1 · Reply

contra7 Sep. 18 at 3:51 PM

$SBFM

0 · Reply

Masterrunner Sep. 17 at 9:51 PM

$SBFM I knew this was going sub-1$ but 20% down is one trading session? 😱 This is going down to 0.30$. Let's go Sleezyballs, time to PUMP IT pre-RS!!!!

2 · Reply

EZ_Money11 Sep. 17 at 8:30 PM

$SBFM been here since after the last RS….anything new here yet?? Figured a buyout by now

1 · Reply

FastMonte Sep. 17 at 8:03 PM

$SBFM Jeez

0 · Reply

Outrun_Sunshine Sep. 17 at 6:44 PM

$SBFM Don't worry - they still have $1.5 million allocated for share buyback. They approved $2 million in like 2022 and only spent $500 k. Relief is on the way! Oh wait... more dilution? Or maybe they'll buy all that bitcoin they allocated funds for a few years ago lmao!!! Cause the only thing shittier than a biopharma... is a crypto biopharma!!!

0 · Reply

Outrun_Sunshine Sep. 17 at 6:11 PM

$SBFM This drop could not have happened to a worse C-suite! What's your unrealized loss and exit strategy @contra7 ? I know you think I get all worried about your position, honestly I don't care if you're down, I am morbidly curious how forthcoming you will be. And when you think you will finally admit you are wrong. You really didn't believe me that just holding and waiting would completely eradicate your money. I hope you do now. Or is ANOTHER non-compliance with NASDAQ all part of the sleeper buyout????

2 · Reply

Suomalainen Sep. 17 at 5:40 PM

$SBFM $0.8763 $9,279,999.12 (100.00%) All Time

0 · Reply

Sunshine Biopharma advances lead Coronavirus drug candidate

Sep 16, 2026, 9:00 AM EDT - 3 days ago

Sunshine Biopharma Advances Lead Coronavirus Drug Candidate into IND-Enabling Studies

2026-08-31T13:25:19.000Z - 19 days ago

Sunshine Biopharma announces Health Canada approval for atenolol

Aug 31, 2026, 9:00 AM EDT - 19 days ago

Health Canada Approves Sunshine Biopharma's Atenolol for Treating and Managing Cardiovascular Conditions

2026-08-28T20:20:09.000Z - 22 days ago

Sunshine Biopharma files to sell 24.48M shares of common stock

2026-08-26T13:35:58.000Z - 24 days ago

Sunshine Biopharma provides update, outlines plans for oncology project

Aug 26, 2026, 9:00 AM EDT - 24 days ago

Sunshine Biopharma Reports In Vivo Tumor Suppression with K1.1 mRNA and Advances Novel mRNA-Cancer Vaccine Strategy for Lung Cancer

2026-08-19T13:11:16.000Z - 4 weeks ago

Sunshine Biopharma receives Canadian regulatory approval for Enalapril

Aug 19, 2026, 9:00 AM EDT - 4 weeks ago

Sunshine Biopharma Receives Canadian Regulatory Approval for Enalapril, Expanding Into $25.94 Billion Global Anti-Hypertensive Drug Market

2026-08-07T13:06:38.000Z - 6 weeks ago

Sunshine Biopharma launches generic amoxicillin formulation in Canada

Aug 7, 2026, 9:00 AM EDT - 6 weeks ago

Sunshine Biopharma Launches Amoxicillin in Canada and Begins Pharmacy Shipments, Targeting an Estimated $4.9 Billion Global Market

2026-08-04T13:16:02.000Z - 6 weeks ago

Sunshine announces approval of generic Dienogest tablets for Canadian market

Aug 4, 2026, 9:00 AM EDT - 6 weeks ago

Sunshine Biopharma Enters the $2.8 Billion Global Dienogest Market with Canadian Regulatory Approval

2026-07-28T12:21:42.000Z - 7 weeks ago

Sunshine Biopharma announces approval of generic Ondansetron tablets

Jul 28, 2026, 8:00 AM EDT - 7 weeks ago

Health Canada Approves Sunshine Biopharma's Ondansetron for Treatment of Chemotherapy-Induced Nausea and Vomiting

2026-07-20T12:45:19.000Z - 2 months ago

Sunshine Biopharma announces publication of new results on MR1-114

Jul 20, 2026, 8:30 AM EDT - 2 months ago

Sunshine Biopharma and University of Arizona Publish Significant New Research Findings

2026-06-25T12:20:47.000Z - 2 months ago

Sunshine Biopharma receives Canadian approval for generic Arimidex

Jun 25, 2026, 8:00 AM EDT - 2 months ago

Sunshine Biopharma Receives Canadian Regulatory Approval for Generic Arimidex(R)

2026-06-01T12:23:56.000Z - 3 months ago

Sunshine Biopharma announces Canadian approval for Rivaroxaban

Jun 1, 2026, 8:00 AM EDT - 3 months ago

Sunshine Biopharma Announces Canadian Approval for Rivaroxaban, a Generic Form of Xarelto(R)

2026-05-29T23:55:22.000Z - 3 months ago

Sunshine Biopharma Inc trading halted, news pending

2026-05-29T13:11:09.000Z - 3 months ago

Sunshine Biopharma issued U.S. patent for coronavirus treatment tech

May 29, 2026, 8:00 AM EDT - 3 months ago

Sunshine Biopharma Announces Issuance of U.S. Patent 12,624,066 B2 Covering Novel Coronavirus Treatment Technology

2026-05-28T14:49:55.000Z - 3 months ago

Sunshine Biopharma announces 1-for-10 reverse split of its common stock

May 28, 2026, 9:00 AM EDT - 3 months ago

Sunshine Biopharma Announces Reverse Stock Split to Maintain NASDAQ Listing

2026-05-21T11:17:11.000Z - 4 months ago

Sunshine announces approval of generic amoxicillin formulation for Canada

May 21, 2026, 7:00 AM EDT - 4 months ago

Sunshine Biopharma Receives Canadian Regulatory Approval for Generic Amoxicillin

2026-05-19T16:21:43.000Z - 4 months ago

3 Penny Stocks to Watch Now, 5/19/26

AIIO GOVX

May 19, 2026, 12:05 PM EDT - 4 months ago

Sunshine Biopharma Inc. Announces Closing of up to $18.0 Million Public Offering

May 18, 2026, 12:15 PM EDT - 4 months ago

Sunshine Biopharma Inc. Announces Pricing of $6.0 Million Public Offering

2026-05-18T12:55:34.000Z - 4 months ago

Why Is Penny Stock Sunshine Biopharma (SBFM) Up Today?

2026-05-12T21:20:04.000Z - 4 months ago

Sunshine Biopharma files to sell 5.825M common units

Apr 6, 2026, 8:30 AM EDT - 5 months ago

Sunshine Biopharma Reports Fiscal 2025 Revenue of $36.3 Million, a 4.1% Increase Over Prior Year

Oct 28, 2025, 2:10 PM EDT - 10 months ago

Sunshine Biopharma Scores a Major Regulatory Win to Market Domperidone in Canada (NASDAQ: SBFM)

Oct 28, 2025, 7:45 AM EDT - 10 months ago

Sunshine Biopharma Gains FDA-Equivalent Clearance in Canada for Domperidone to Treat Cancer-related Nausea

Oct 20, 2025, 7:45 AM EDT - 11 months ago

Sunshine Biopharma Launches STD, Acne and Lyme Disease Therapy Doxycycline

Oct 16, 2025, 7:45 AM EDT - 11 months ago

Sunshine Biopharma Launches Cholesterol Fighting Medicine Pravastatin

Oct 14, 2025, 10:45 AM EDT - 11 months ago

Sunshine Biopharma is Proving That Riding Momentum is an Effective Strategy (NASDAQ:SBFM)

Oct 14, 2025, 8:50 AM EDT - 11 months ago

Sunshine Biopharma Proves Microcap Ambition Can Deliver Large-Cap Level Execution (NASDAQ: SBFM)

Oct 14, 2025, 7:00 AM EDT - 11 months ago

Sunshine Biopharma Allocates $5 Million for Investment in Bitcoin as Strategic Reserve Asset to Enhance Treasury Resilience

Oct 9, 2025, 8:00 AM EDT - 11 months ago

Sunshine Biopharma and University of Arizona Develop a Potent New Series of Protease Inhibitors for Treatment of SARS Coronavirus Infections

Jul 2, 2025, 8:00 AM EDT - 1 year ago

Sunshine Biopharma Launches NIOPEG(R) Into $10 Billion Biologics Market

Jun 11, 2025, 8:30 AM EDT - 1 year ago

Sunshine Biopharma Launches Generic Gabapentin for Neuropathic Pain in the Canadian Segment of the Global $1.92 Billion Market

May 15, 2025, 4:15 PM EDT - 1 year ago

Sunshine Biopharma Reports 2025 First Quarter Results, Revenues Up 18% Over Same Period Last Year

May 6, 2025, 8:30 AM EDT - 1 year ago

Sunshine Biopharma Launches Generic Lurasidone for Schizophrenia in the Canadian Sector of the Global $1.2 Billion Market

Apr 21, 2025, 8:30 AM EDT - 1 year ago

Sunshine Biopharma Launches Everolimus In Canada, an Oncology Drug with an Estimated Global Market of $2.5 Billion

Apr 3, 2025, 10:50 AM EDT - 1 year ago

Sunshine Biopharma Inc. Announces Closing of $2.46 Million Registered Direct Offering

Apr 2, 2025, 1:20 PM EDT - 1 year ago

Sunshine Biopharma Inc. Announces $2.46 Million Registered Direct Offering Priced at the Market Under Nasdaq Rules

Apr 2, 2025, 8:00 AM EDT - 1 year ago

Sunshine Biopharma Announces Positive Results of mRNA Therapy for Cancer

Apr 1, 2025, 5:09 PM EDT - 1 year ago

Sunshine Biopharma Reports Revenue of $34.9M in Fiscal 2024, Up 45% From Last Year

Mar 24, 2025, 8:00 AM EDT - 1 year ago

Sunshine Biopharma Expands Presence in the $53.9 Billion Global Antibiotics Market with the Acquisition of Marketing Rights for Two New Antibiotics in Canada

Mar 10, 2025, 9:00 AM EDT - 1 year ago

Sunshine Biopharma Acquires Rights to Launch Two Gastrointestinal Drugs in the Canadian $200 Million Market

Jan 21, 2025, 8:00 AM EST - 1 year ago

Sunshine Biopharma Expands Its Product Line to 69 Generic Prescription Drugs by Launching Olanzapine and Olanzapine ODT

Jan 15, 2025, 8:00 AM EST - 1 year ago

Sunshine Biopharma Announces the Appointment of New Chief Commercial Officer

Dec 9, 2024, 7:30 AM EST - 1 year ago

Sunshine Biopharma Announces Novel Inhibitor for Sars Coronavirus

Dec 4, 2024, 4:05 PM EST - 1 year ago

Sunshine Biopharma Launches a New Generic Prescription Drug

Dec 2, 2024, 8:00 AM EST - 1 year ago

Sunshine Biopharma Announces Breakthrough Research Results on the Company's K1.1 mRNA Product as a Novel Therapeutic Agent for Human Hepatocellular Carcinoma

Nov 6, 2024, 8:00 AM EST - 1 year ago

Sunshine Biopharma Reports 2024 Third Quarter Results: Year-To-Date Revenues Up 54%

Sep 26, 2024, 8:00 AM EDT - 1 year ago

Sunshine Biopharma Launches Two New Generic Prescription Drugs

Sep 4, 2024, 8:00 AM EDT - 2 years ago

Sunshine Biopharma Announces Publication of Significant Coronavirus Research Results in the Journal of Medicinal Chemistry

Aug 26, 2024, 8:00 AM EDT - 2 years ago

Sunshine Biopharma Has Launched Nine New Generic Prescription Drugs in 2024: Now Marketing Sixty-One Generic Drugs in Canada

Aug 19, 2024, 8:00 AM EDT - 2 years ago

Sunshine Biopharma Reports 2024 Second Quarter Results: Second QTR Revenues up 67%, YTD Revenues up 61%

Aug 6, 2024, 8:00 AM EDT - 2 years ago

Sunshine Biopharma Announces Reverse Stock Split

Apr 19, 2024, 8:00 AM EDT - 2 years ago

Sunshine Biopharma's Nora Pharma Receives Health Canada Approval for Niopeg(R), a Biosimilar of Neulasta(R)

Apr 1, 2024, 8:00 AM EDT - 2 years ago

Sunshine Biopharma Reports Operating Results for the Fiscal Year Ended December 31, 2023

Feb 15, 2024, 9:15 AM EST - 2 years ago

Sunshine Biopharma, Inc. Announces Closing of $10.0 Million Underwritten Public Offering

Feb 13, 2024, 9:00 AM EST - 2 years ago

Sunshine Biopharma, Inc. Announces Pricing of $10.0 Million Underwritten Public Offering

Masterrunner Sep. 18 at 6:27 PM

2 · Reply

contra7 Sep. 18 at 6:00 PM

$SBFM https://www.sandoz.com/sandoz-receives-regulatory-approval-generic-semaglutide-canada-paving-way-expand-patient-access-key/

1 · Reply

Kalini67 Sep. 18 at 4:02 PM

$SBFM

1 · Reply

contra7 Sep. 18 at 3:51 PM

$SBFM

0 · Reply

Masterrunner Sep. 17 at 9:51 PM

$SBFM I knew this was going sub-1$ but 20% down is one trading session? 😱 This is going down to 0.30$. Let's go Sleezyballs, time to PUMP IT pre-RS!!!!

2 · Reply

EZ_Money11 Sep. 17 at 8:30 PM

$SBFM been here since after the last RS….anything new here yet?? Figured a buyout by now

1 · Reply

FastMonte Sep. 17 at 8:03 PM

$SBFM Jeez

0 · Reply

Outrun_Sunshine Sep. 17 at 6:44 PM

0 · Reply

Outrun_Sunshine Sep. 17 at 6:11 PM

2 · Reply

Suomalainen Sep. 17 at 5:40 PM

$SBFM $0.8763 $9,279,999.12 (100.00%) All Time

0 · Reply

contra7 Sep. 17 at 5:30 PM

$SBFM

1 · Reply

Paxter Sep. 17 at 5:09 PM

$SBFM yeah a big joke that start during covid and still make me sick nora should have been a good pill to cure that stock illness but god knows why the joke is still going on and no pill to cure anything i feel the pain of people who are loosing big or small money have a nice day

0 · Reply

Kalini67 Sep. 17 at 4:41 PM

$SBFM Please just pump it so I can sell my warrants, just 11 cents Please so I can get my 9 cents average!

1 · Reply

KeailiIlani4U Sep. 17 at 4:08 PM

$SBFM Come’n on my 16 shares I got an average of 1.07 am losing biggly!!!🥸

0 · Reply

hotslots Sep. 17 at 2:12 PM

$SBFM .50 incoming

2 · Reply

djgestates Sep. 17 at 2:06 PM

$SBFM I hate laughing because of all of those who have lost money at the hands of Steve Slilaty (myself included), but it has become such a joke that it is hard not too.

2 · Reply

Masterrunner Sep. 17 at 12:22 PM

$SBFM you know this is going sub-1$; RS has been approved "by the board" again 🤣

0 · Reply

martyn78 Sep. 17 at 7:40 AM

Been tapped into @_ProfessorGamma for a minute now. The way they spot some of these plays before they run is nuts! Wise to be paying attention to this account, give him a proper follow 👍 $SBFM & $ORKT I'm with them

1 · Reply

Ejannsen Sep. 17 at 12:51 AM

$SBFM This tie should be delisted and kicked off Stocktwits. This is their MO and has been for the last five years. This is what Dr Shitty deserves.

0 · Reply

FatCatFenix Sep. 16 at 11:22 PM

$SBFM Just wait till the warrants get VWAP repriced into the money, followed by another RS 🤣 They currently have 4,310,301 common shares outstanding as of Sept. 15. 1-for-2: 2.155M shares 1-for-5: 862K 1-for-10: 431K 1-for-20: 216K Beautiful Buyout Setup @contra7

0 · Reply

hotslots Sep. 16 at 10:34 PM

$SBFM well thatll take us down to 195k shares temporarily!! Oh man you cant make this stuff up

0 · Reply

2pumps1dump Sep. 16 at 9:27 PM

$SBFM @contra7 blind bro…smh

1 · Reply

Market Cap	3.49M
Revenue (ttm)	36.31M
Net Income (ttm)	-5.98M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-16.47%
Debt to Equity Ratio	0.00

Volume	157,700
Avg Vol	634,032
Day's Range	N/A - N/A
Shares Out	3.88M
Stochastic %K	19%
Beta	1.17
Analysts	Sell
Price Target	$56.00